Loading...

Ligand Pharmaceuticals, Inc.

LGNXZPNK
Healthcare
Medical - Pharmaceuticals
$0.002
$-0.00(-10.26%)

Ligand Pharmaceuticals, Inc. (LGNXZ) Company Profile & Overview

Explore Ligand Pharmaceuticals, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Ligand Pharmaceuticals, Inc. (LGNXZ) Company Profile & Overview

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.

SectorHealthcare
IndustryMedical - Pharmaceuticals
CEOTodd C. Davis

Contact Information

858 550 7500
555 Heritage Drive, Jupiter, DE, 33458

Company Facts

68 Employees
CountryUS
Actively Trading

Frequently Asked Questions

;